Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Harris

Showing results (71-80 of 484) with videos related to

Pageof 49
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Cancer risk and low-penetrance susceptibility genes in gene-environment interactionsP G Shields, C C Harris
Acta Oncologica (Stockholm, Sweden)|January 5, 2002
p53-mediated apoptosis and genomic instability diseasesA I Robles, C C Harris
Critical Reviews in Oncology/Hematology|January 1, 1990
Cellular and molecular biological aspects of human bronchogenic carcinogenesisJ C Willey, C C Harris
Experimental Cell Research|July 1, 1983
Tissue-specific expression of keratin proteins in human esophageal and epidermal epithelium and their cultured keratinocytesS P Banks-Schlegel, C C Harris
IARC Scientific Publications|January 1, 1988
Synchronous fluorescence spectrophotometry of benzo[a]pyrene diol epoxide-DNA adducts: a tool for detection of in-vitro and in-vivo DNA damage by exposure to benzo[a]pyreneK Vähäkangas, O Pelkonen, C C Harris
Journal of the Royal Army Medical Corps|January 26, 2010
Paediatric intensive care in the field hospitalC C Harris, J J K McNicholas
Cancer Research|March 1, 1984
Aberrant expression of keratin proteins and cross-linked envelopes in human esophageal carcinomasS P Banks-Schlegel, C C Harris
IARC Scientific Publications|January 1, 1984
Interindividual variation in carcinogen metabolism, DNA damage and DNA repairK Vahakangas, H Autrup, C C Harris
Carcinogenesis|August 1, 1985
An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adductsK Vahakangas, A Haugen, C C Harris
Current Drug Targets|May 16, 2009
ING proteins as potential anticancer drug targetsM Unoki, K Kumamoto, C C Harris
Pageof 49

Showing results (71-80 of 484) with videos related to

Sort By:
Pageof 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Cancer risk and low-penetrance susceptibility genes in gene-environment interactionsP G Shields, C C Harris
Acta Oncologica (Stockholm, Sweden)|January 5, 2002
p53-mediated apoptosis and genomic instability diseasesA I Robles, C C Harris
Critical Reviews in Oncology/Hematology|January 1, 1990
Cellular and molecular biological aspects of human bronchogenic carcinogenesisJ C Willey, C C Harris
Experimental Cell Research|July 1, 1983
Tissue-specific expression of keratin proteins in human esophageal and epidermal epithelium and their cultured keratinocytesS P Banks-Schlegel, C C Harris
IARC Scientific Publications|January 1, 1988
Synchronous fluorescence spectrophotometry of benzo[a]pyrene diol epoxide-DNA adducts: a tool for detection of in-vitro and in-vivo DNA damage by exposure to benzo[a]pyreneK Vähäkangas, O Pelkonen, C C Harris
Journal of the Royal Army Medical Corps|January 26, 2010
Paediatric intensive care in the field hospitalC C Harris, J J K McNicholas
Cancer Research|March 1, 1984
Aberrant expression of keratin proteins and cross-linked envelopes in human esophageal carcinomasS P Banks-Schlegel, C C Harris
IARC Scientific Publications|January 1, 1984
Interindividual variation in carcinogen metabolism, DNA damage and DNA repairK Vahakangas, H Autrup, C C Harris
Carcinogenesis|August 1, 1985
An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adductsK Vahakangas, A Haugen, C C Harris
Current Drug Targets|May 16, 2009
ING proteins as potential anticancer drug targetsM Unoki, K Kumamoto, C C Harris
Pageof 49